2 results
Approved WMORecruiting
The primary objective of the trial is to evaluate whether nintedanib given as second-line therapy for advanced, inoperable and/or metastatic STSprolongs progression-free survival when compared with ifosfamide.Secondary objectives are to evaluate the…
Approved WMORecruiting
The objective of the study is to compare conventional therapy with biological therapy in patients with early rheumatoid arthritis.